PPARα affects hepatic lipid homeostasis by perturbing necroptosis signals in the intestinal epithelium

IF 14.7 1区 医学 Q1 PHARMACOLOGY & PHARMACY Acta Pharmaceutica Sinica. B Pub Date : 2024-08-30 DOI:10.1016/j.apsb.2024.08.021
Shufang Na, Yanjie Fan, HongLei Chen, Ling Li, Guolin Li, Furong Zhang, Rongyan Wang, Yafei Yang, Zixia Shen, Zhuang Peng, Yafei Wu, Yong Zhu, Zheqiong Yang, Guicheng Dong, Qifa Ye, Jiang Yue
{"title":"PPARα affects hepatic lipid homeostasis by perturbing necroptosis signals in the intestinal epithelium","authors":"Shufang Na, Yanjie Fan, HongLei Chen, Ling Li, Guolin Li, Furong Zhang, Rongyan Wang, Yafei Yang, Zixia Shen, Zhuang Peng, Yafei Wu, Yong Zhu, Zheqiong Yang, Guicheng Dong, Qifa Ye, Jiang Yue","doi":"10.1016/j.apsb.2024.08.021","DOIUrl":null,"url":null,"abstract":"Rapid turnover of the intestinal epithelium is a critical strategy to balance the uptake of nutrients and defend against environmental insults, whereas inappropriate death promotes the spread of inflammation. PPAR is highly expressed in the small intestine and regulates the absorption of dietary lipids. However, as a key mediator of inflammation, the impact of intestinal PPAR signaling on cell death pathways is unknown. Here, we show that deficiency of intestinal epithelium up-regulates necroptosis signals, disrupts the gut vascular barrier, and promotes LPS translocation into the liver. Intestinal deficiency drives age-related hepatic steatosis and aggravates hepatic fibrosis induced by a high-fat plus high-sucrose diet (HFHS). PPAR levels correlate with TRIM38 and MLKL in the human ileum. Inhibition of PPAR up-regulates necroptosis signals in the intestinal organoids triggered by TNF- and LPS stimuli TRIM38/TRIF and CREB3L3/MLKL pathways. Butyric acid ameliorates hepatic steatosis induced by intestinal deficiency through the inhibition of necroptosis. Our data suggest that intestinal PPAR is essential for the maintenance of microenvironmental homeostasis and the spread of inflammation the gut–liver axis.","PeriodicalId":6906,"journal":{"name":"Acta Pharmaceutica Sinica. B","volume":"59 1","pages":""},"PeriodicalIF":14.7000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmaceutica Sinica. B","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1016/j.apsb.2024.08.021","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Rapid turnover of the intestinal epithelium is a critical strategy to balance the uptake of nutrients and defend against environmental insults, whereas inappropriate death promotes the spread of inflammation. PPAR is highly expressed in the small intestine and regulates the absorption of dietary lipids. However, as a key mediator of inflammation, the impact of intestinal PPAR signaling on cell death pathways is unknown. Here, we show that deficiency of intestinal epithelium up-regulates necroptosis signals, disrupts the gut vascular barrier, and promotes LPS translocation into the liver. Intestinal deficiency drives age-related hepatic steatosis and aggravates hepatic fibrosis induced by a high-fat plus high-sucrose diet (HFHS). PPAR levels correlate with TRIM38 and MLKL in the human ileum. Inhibition of PPAR up-regulates necroptosis signals in the intestinal organoids triggered by TNF- and LPS stimuli TRIM38/TRIF and CREB3L3/MLKL pathways. Butyric acid ameliorates hepatic steatosis induced by intestinal deficiency through the inhibition of necroptosis. Our data suggest that intestinal PPAR is essential for the maintenance of microenvironmental homeostasis and the spread of inflammation the gut–liver axis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PPARα 通过干扰肠上皮细胞的坏死信号影响肝脏脂质稳态
肠上皮细胞的快速更替是平衡营养吸收和抵御环境损伤的关键策略,而不适当的死亡则会促进炎症的扩散。PPAR 在小肠中高度表达,调节饮食中脂类的吸收。然而,作为炎症的关键介质,肠道 PPAR 信号对细胞死亡途径的影响尚不清楚。在这里,我们发现肠上皮细胞缺乏会上调坏死信号,破坏肠道血管屏障,并促进 LPS 转位至肝脏。肠道缺乏会导致与年龄相关的肝脂肪变性,并加重高脂高蔗糖饮食(HFHS)诱导的肝纤维化。PPAR 水平与人体回肠中的 TRIM38 和 MLKL 相关。抑制 PPAR 可上调 TNF 和 LPS 刺激 TRIM38/TRIF 和 CREB3L3/MLKL 通路引发的肠器官组织坏死信号。丁酸可通过抑制坏死诱导的肠道缺乏症改善肝脏脂肪变性。我们的数据表明,肠道 PPAR 对维持微环境稳态和肠肝轴炎症的扩散至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
22.40
自引率
5.50%
发文量
1051
审稿时长
19 weeks
期刊介绍: The Journal of the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association oversees the peer review process for Acta Pharmaceutica Sinica. B (APSB). Published monthly in English, APSB is dedicated to disseminating significant original research articles, rapid communications, and high-quality reviews that highlight recent advances across various pharmaceutical sciences domains. These encompass pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, and pharmacokinetics. A part of the Acta Pharmaceutica Sinica series, established in 1953 and indexed in prominent databases like Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, and Current Bibliography on Science and Technology, APSB is sponsored by the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association. Its production and hosting are facilitated by Elsevier B.V. This collaborative effort ensures APSB's commitment to delivering valuable contributions to the pharmaceutical sciences community.
期刊最新文献
Table of Contents Characteristic roadmap of linker governs the rational design of PROTACs Targeted isolation of antiviral cinnamoylphloroglucinol-terpene adducts from Cleistocalyx operculatus by building blocks-based molecular networking approach A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases Reprogramming tumor-associated macrophages and inhibiting tumor neovascularization by targeting MANF–HSF1–HSP70-1 pathway: An effective treatment for hepatocellular carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1